BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

457 related articles for article (PubMed ID: 29475431)

  • 1. The effect of CBT and its modifications for relapse prevention in major depressive disorder: a systematic review and meta-analysis.
    Zhang Z; Zhang L; Zhang G; Jin J; Zheng Z
    BMC Psychiatry; 2018 Feb; 18(1):50. PubMed ID: 29475431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effectiveness and cost-effectiveness of mindfulness-based cognitive therapy compared with maintenance antidepressant treatment in the prevention of depressive relapse/recurrence: results of a randomised controlled trial (the PREVENT study).
    Kuyken W; Hayes R; Barrett B; Byng R; Dalgleish T; Kessler D; Lewis G; Watkins E; Morant N; Taylor RS; Byford S
    Health Technol Assess; 2015 Sep; 19(73):1-124. PubMed ID: 26379122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of Recurrence After Recovery From a Major Depressive Episode With Antidepressant Medication Alone or in Combination With Cognitive Behavioral Therapy: Phase 2 of a 2-Phase Randomized Clinical Trial.
    DeRubeis RJ; Zajecka J; Shelton RC; Amsterdam JD; Fawcett J; Xu C; Young PR; Gallop R; Hollon SD
    JAMA Psychiatry; 2020 Mar; 77(3):237-245. PubMed ID: 31799993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of relapse/recurrence in major depressive disorder with either mindfulness-based cognitive therapy or cognitive therapy.
    Farb N; Anderson A; Ravindran A; Hawley L; Irving J; Mancuso E; Gulamani T; Williams G; Ferguson A; Segal ZV
    J Consult Clin Psychol; 2018 Feb; 86(2):200-204. PubMed ID: 29265831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relapse/Recurrence Prevention in Major Depressive Disorder: 26-Month Follow-Up of Mindfulness-Based Cognitive Therapy Versus an Active Control.
    Shallcross AJ; Willroth EC; Fisher A; Dimidjian S; Gross JJ; Visvanathan PD; Mauss IB
    Behav Ther; 2018 Sep; 49(5):836-849. PubMed ID: 30146148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of mindfulness-based cognitive therapy for prevention of relapse in recurrent major depressive disorder: a systematic review and meta-analysis.
    Piet J; Hougaard E
    Clin Psychol Rev; 2011 Aug; 31(6):1032-40. PubMed ID: 21802618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-Utility Analysis of Mindfulness-Based Cognitive Therapy Versus Antidepressant Pharmacotherapy for Prevention of Depressive Relapse in a Canadian Context: Analyse coût-utilité de la thérapie cognitive basée sur la pleine conscience contre la pharmacothérapie antidépressive pour prévenir la rechute de la dépression en contexte canadien.
    Pahlevan T; Ung C; Segal Z
    Can J Psychiatry; 2020 Aug; 65(8):568-576. PubMed ID: 32031000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness and cost-effectiveness of mindfulness-based cognitive therapy compared with maintenance antidepressant treatment in the prevention of depressive relapse or recurrence (PREVENT): a randomised controlled trial.
    Kuyken W; Hayes R; Barrett B; Byng R; Dalgleish T; Kessler D; Lewis G; Watkins E; Brejcha C; Cardy J; Causley A; Cowderoy S; Evans A; Gradinger F; Kaur S; Lanham P; Morant N; Richards J; Shah P; Sutton H; Vicary R; Weaver A; Wilks J; Williams M; Taylor RS; Byford S
    Lancet; 2015 Jul; 386(9988):63-73. PubMed ID: 25907157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adding mindfulness-based cognitive therapy to maintenance antidepressant medication for prevention of relapse/recurrence in major depressive disorder: Randomised controlled trial.
    Huijbers MJ; Spinhoven P; Spijker J; Ruhé HG; van Schaik DJ; van Oppen P; Nolen WA; Ormel J; Kuyken W; van der Wilt GJ; Blom MB; Schene AH; Donders AR; Speckens AE
    J Affect Disord; 2015 Nov; 187():54-61. PubMed ID: 26318271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of Mindfulness-Based Cognitive Therapy in Prevention of Depressive Relapse: An Individual Patient Data Meta-analysis From Randomized Trials.
    Kuyken W; Warren FC; Taylor RS; Whalley B; Crane C; Bondolfi G; Hayes R; Huijbers M; Ma H; Schweizer S; Segal Z; Speckens A; Teasdale JD; Van Heeringen K; Williams M; Byford S; Byng R; Dalgleish T
    JAMA Psychiatry; 2016 Jun; 73(6):565-74. PubMed ID: 27119968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patients with a preference for medication do equally well in mindfulness-based cognitive therapy for recurrent depression as those preferring mindfulness.
    Huijbers MJ; Spinhoven P; van Schaik DJ; Nolen WA; Speckens AE
    J Affect Disord; 2016 May; 195():32-9. PubMed ID: 26852095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antidepressant monotherapy vs sequential pharmacotherapy and mindfulness-based cognitive therapy, or placebo, for relapse prophylaxis in recurrent depression.
    Segal ZV; Bieling P; Young T; MacQueen G; Cooke R; Martin L; Bloch R; Levitan RD
    Arch Gen Psychiatry; 2010 Dec; 67(12):1256-64. PubMed ID: 21135325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Study protocol for a randomized controlled trial comparing mindfulness-based cognitive therapy with maintenance anti-depressant treatment in the prevention of depressive relapse/recurrence: the PREVENT trial.
    Kuyken W; Byford S; Byng R; Dalgleish T; Lewis G; Taylor R; Watkins ER; Hayes R; Lanham P; Kessler D; Morant N; Evans A
    Trials; 2010 Oct; 11():99. PubMed ID: 20961444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Update to the study protocol for a randomized controlled trial comparing mindfulness-based cognitive therapy with maintenance anti-depressant treatment depressive relapse/recurrence: the PREVENT trial.
    Kuyken W; Byford S; Byng R; Dalgleish T; Lewis G; Taylor R; Watkins ER; Hayes R; Lanham P; Kessler D; Morant N; Evans A
    Trials; 2014 Jun; 15():217. PubMed ID: 24916319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of relapse/recurrence in major depression by mindfulness-based cognitive therapy.
    Teasdale JD; Segal ZV; Williams JM; Ridgeway VA; Soulsby JM; Lau MA
    J Consult Clin Psychol; 2000 Aug; 68(4):615-23. PubMed ID: 10965637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Sequential Integration of Pharmacotherapy and Psychotherapy in the Treatment of Major Depressive Disorder: A Meta-Analysis of the Sequential Model and a Critical Review of the Literature.
    Guidi J; Tomba E; Fava GA
    Am J Psychiatry; 2016 Feb; 173(2):128-37. PubMed ID: 26481173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A lifetime approach to major depressive disorder: The contributions of psychological interventions in preventing relapse and recurrence.
    Bockting CL; Hollon SD; Jarrett RB; Kuyken W; Dobson K
    Clin Psychol Rev; 2015 Nov; 41():16-26. PubMed ID: 25754289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Practice of therapy acquired regulatory skills and depressive relapse/recurrence prophylaxis following cognitive therapy or mindfulness based cognitive therapy.
    Segal ZV; Anderson AK; Gulamani T; Dinh Williams LA; Desormeau P; Ferguson A; Walsh K; Farb NAS
    J Consult Clin Psychol; 2019 Feb; 87(2):161-170. PubMed ID: 30431297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors associated with relapse and recurrence of major depressive disorder in patients starting mindfulness-based cognitive therapy.
    de Klerk-Sluis JM; Huijbers MJ; Löcke S; Spijker J; Spinhoven P; Speckens AEM; Ruhe HG
    Depress Anxiety; 2022 Feb; 39(2):113-122. PubMed ID: 34752681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mindfulness-based cognitive therapy to prevent relapse in recurrent depression.
    Kuyken W; Byford S; Taylor RS; Watkins E; Holden E; White K; Barrett B; Byng R; Evans A; Mullan E; Teasdale JD
    J Consult Clin Psychol; 2008 Dec; 76(6):966-78. PubMed ID: 19045965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.